Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome

Antiphospholipid antibody syndrome (APS) is a systemic autoimmune disease characterized by arterial and/or venous thrombosis, pregnancy morbidity in the presence of circulating “anti-phospholipid antibodies” (aPL). One of the main target antigens of aPL is β2-glycoprotein I (β2-GPI). APS may occur a...

Full description

Bibliographic Details
Main Authors: Valeria Manganelli, Simona Truglia, Antonella Capozzi, Cristiano Alessandri, Gloria Riitano, Francesca Romana Spinelli, Fulvia Ceccarelli, Silvia Mancuso, Tina Garofalo, Agostina Longo, Guido Valesini, Maurizio Sorice, Fabrizio Conti, Roberta Misasi
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.00460/full